Company: ARWR
Filing Date: 2025-01-29
Form Type: DEF 14A
Source: 0001628280-25-002848
Chunk: 34

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-01-29
Form: DEF 14A
Chunk 34
---
 long-term equity component, thereby making a substantial portion of our CEO’s and each additional executive officer’s target total direct compensation dependent upon our stock price and/or total stockholder return. 
 ✓“Double Trigger” Feature for Acceleration of CEO Equity Awards— The outstanding equity awards granted to our CEO pursuant to our 2013 Incentive Plan and 2021 Incentive Plan provide that, upon a change in control of the Company, the vesting of such awards will accelerate only in the event of a subsequent involuntary termination of employment (a “double-trigger” arrangement).                                                                                   |     | ✘No Executive Retirement Plans.We do not offer pension arrangements or retirement plans or arrangements to our executive officers that are different from or in addition to those offered to our other employees.                                                                                               
 ✘No Perquisites.We do not provide perquisites or other personal benefits to our executive officers.                                                                                                                                                                                                             
 ✘No Special Welfare or Health Benefits.Our executive officers participate in broad-based Company-sponsored health and welfare benefits programs generally on the same basis as our other full-time, salaried employees.                                                                                         
 ✘No Post-Employment Tax Payment Reimbursement.We do not provide any tax reimbursement payments (including “gross-ups”) on any severance or change-in-control payments or benefits.                                                                                                                              
 ✘No Hedging and Limit on Pledging of Our Equity Securities.We prohibit our employees, executive officers and the non-employee members of our Board from hedging our equity securities. Our board members and executive officers may pledge up to 75% of owned and vested shares with the approval of our Board. 
 ✘No Dividends or Dividend Equivalents Payable on Unvested Equity Awards.We do not pay dividends or dividend equivalents on unvested RSU awards or PRSU awards.                                                                                                                                                  
 ✘No Stock Option Re-pricing.Our employee stock plan does not permit options to purchase shares of our common stock to be repriced to a lower exercise or strike price without the approval of our stockholders.                                                                                                 |

| 32 |

2025 PROXY STATEMENT Executive Compensation Executive Compensation Philosophy Our executive compensation philosophy reflects our two fundamental objectives: • to attract, motivate and retain a highly skilled team of executives; and • to align our executive officers’ interests with those of our stockholders by rewarding short-term and long-term performance and aligning compensation to increases in stockholder value. We believe that the compensation of our executive officers should be directly linked to the achievement of specific objectives that are expected to increase stock